
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1083 | 972 | 1083 | 1021 | 1170 | 1743 |
Fund Return | 8.29% | -2.76% | 8.29% | 0.69% | 3.18% | 5.71% |
Place in category | 100 | 31 | 100 | 35 | 314 | 103 |
% in Category | 15 | 5 | 15 | 6 | 67 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 7.36B | -6.77 | 7.41 | 11.36 | ||
UBS CH Vitainvest 50 World U | 4.01B | 7.32 | -1.50 | 2.35 | ||
UBS CH Institutional Fund 2 EquiPAX | 3.95B | -4.31 | 6.73 | 9.07 | ||
UBS CH Institutional Fund 2 EquiSCA | 2.52B | 3.61 | 3.69 | 7.88 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.52B | -0.41 | 2.98 | 6.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.36B | 9.97 | 4.26 | 6.64 | ||
Pictet CH Institutional Swiss EquiZ | 1.92B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 1.92B | 6.32 | 1.38 | 6.61 | ||
Pictet CH Institutional Swiss EquZD | 1.92B | 6.45 | 1.86 | 7.11 | ||
Pictet CH Institutional Swiss EquiP | 1.92B | 6.27 | 1.17 | 6.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 9.50 | 86.38 | +0.38% | |
Novartis | CH0012005267 | 9.22 | 90.20 | +1.65% | |
UBS Group | CH0244767585 | 9.04 | 23.20 | -1.11% | |
Roche Holding Participation | CH0012032048 | 9.03 | 255.40 | +1.47% | |
Zurich Insurance Group | CH0011075394 | 8.87 | 553.60 | +2.52% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review